Huidong Shi

22PUBLICATIONS
68CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursAutoimmunityMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Nov 08, 2026
Fast receptor-antigen dissociation kinetics promote CAR-T cell tumor infiltration, functional fitness, and antitumor efficacy in solid tumors.

|Sep 26, 2026
Elevated dNTP Pool Levels Impair Homologous Recombination and Enhance Glioblastoma Sensitivity to Irradiation and Temozolomide.

|Oct 15, 2025
Genomic Analysis Defines Increased Circulating, Leukemia-Induced Macrophages That Promote Immune Suppression in Mouse Models of FGFR1-Driven Leukemogenesis.

Ting Zhang, Atsuko Matsunaga, Xiaocui Lu

|Aug 26, 2025
Slc7a5 promotes T cell anti-tumor immunity through sustaining cytotoxic T lymphocyte effector function.

Chunwan Lu, Liyan Liang, Yanmin Wu

|Aug 01, 2025
Lipid nanoparticle-delivered IFNα2 activates Cxcl9 to increase T cell tumor recruitment to suppress lung metastasis.

Kendra Fick, Nicholas Kerns, Yang Zhao

|Mar 12, 2025
UFL1 promotes survival and function of virtual memory CD8 T cells.

Brinda Bhatt, Kunal Kumar, Huidong Shi

Pageof 4

Frequent Collaborators

8 joint publications

Zhuoqi Liu

2 joint publications

Mercy Kehinde-Ige

2 joint publications

Yukai He

2 joint publications

Ali S Arbab